Proteomic and lipidomic signatures of lipid metabolism in NASH-associated hepatocellular carcinoma.
about
Global Analysis of Mouse Polyomavirus Infection Reveals Dynamic Regulation of Viral and Host Gene Expression and Promiscuous Viral RNA EditingA New Strategy for Analyzing Time-Series Data Using Dynamic Networks: Identifying Prospective Biomarkers of Hepatocellular Carcinoma.Metabolism dysregulation induces a specific lipid signature of nonalcoholic steatohepatitis in patientsShort term feeding of a high fat diet exerts an additive effect on hepatocellular damage and steatosis in liver-specific PTEN knockout miceSmall nucleolar RNA 113-1 suppresses tumorigenesis in hepatocellular carcinomaSerum complement C3f and fibrinopeptide A are potential novel diagnostic biomarkers for non-alcoholic fatty liver disease: a study in Qingdao Twins.Fibrogenesis and Carcinogenesis in Nonalcoholic Steatohepatitis (NASH): Involvement of Matrix Metalloproteinases (MMPs) and Tissue Inhibitors of Metalloproteinase (TIMPs).Elevated free cholesterol in a p62 overexpression model of non-alcoholic steatohepatitis.Activation of ATP citrate lyase by mTOR signal induces disturbed lipid metabolism in hepatitis B virus pre-S2 mutant tumorigenesis.Decreased level of phosphatidylcholine (16:0/20:4) in multiple myeloma cells compared to plasma cells: a single-cell MALDI-IMS approach.Soybean Oil Is More Obesogenic and Diabetogenic than Coconut Oil and Fructose in Mouse: Potential Role for the Liver.Systematic Analysis of Gene Expression Alterations and Clinical Outcomes for Long-Chain Acyl-Coenzyme A Synthetase Family in Cancer.The Subtle Balance between Lipolysis and Lipogenesis: A Critical Point in Metabolic Homeostasis.Serum Metabolomics to Identify the Liver Disease-Specific Biomarkers for the Progression of Hepatitis to Hepatocellular Carcinoma.The hepatic lipidome: a gateway to understanding the pathogenesis of alcohol-induced fatty liverDifferentiation therapy for hepatocellular carcinoma: Multifaceted effects of miR-148a on tumor growth and phenotype and liver fibrosis.NAFLD causes selective CD4(+) T lymphocyte loss and promotes hepatocarcinogenesis.Dietary fatty acids and risk of hepatocellular carcinoma in the Singapore Chinese health study.Elovl6 is a poor prognostic predictor in breast cancer.Phospholipid profiling identifies acyl chain elongation as a ubiquitous trait and potential target for the treatment of lung squamous cell carcinoma.Lipidomic Signatures and Associated Transcriptomic Profiles of Clear Cell Renal Cell CarcinomaHepatic and serum lipid signatures specific to nonalcoholic steatohepatitis in murine models.Stearoyl-CoA Desaturase Promotes Liver Fibrosis and Tumor Development in Mice via a Wnt Positive-Signaling Loop by Stabilization of Low-Density Lipoprotein-Receptor-Related Proteins 5 and 6.Tissue-specific NETs alter genome organization and regulation even in a heterologous system.Bioanalytical techniques in nontargeted clinical lipidomics.Molecular Liver Cancer Prevention in Cirrhosis by Organ Transcriptome Analysis and Lysophosphatidic Acid Pathway Inhibition.Systematic integration of molecular profiles identifies miR-22 as a regulator of lipid and folate metabolism in breast cancer cells.Inhibition of ATP citrate lyase induces triglyceride accumulation with altered fatty acid composition in cancer cells.Pre-S2 Mutant-Induced Mammalian Target of Rapamycin Signal Pathways as Potential Therapeutic Targets for Hepatitis B Virus-Associated Hepatocellular Carcinoma.Fatty acid elongation in non-alcoholic steatohepatitis and hepatocellular carcinoma.n-3 Fatty acids modulate the mRNA expression of the Nlrp3 inflammasome and Mtor in the liver of rats fed with high-fat or high-fat/fructose diets.The IGF2 mRNA binding protein p62/IGF2BP2-2 induces fatty acid elongation as a critical feature of steatosis.Overexpression of the androgen receptor in human hepatoma cells and its effect on fatty acid metabolism.Multifunctional Effects of a Small-Molecule STAT3 Inhibitor on NASH and Hepatocellular Carcinoma in Mice.A distinct function of the retinoblastoma protein in the control of lipid composition identified by lipidomic profiling.Differences in elongation of very long chain fatty acids and fatty acid metabolism between triple-negative and hormone receptor-positive breast cancer.The Role of Diagnosis and Treatment of Underlying Liver Disease for the Prognosis of Primary Liver Cancer.Metabolomics and eicosanoid analysis identified serum biomarkers for distinguishing hepatocellular carcinoma from hepatitis B virus-related cirrhosis.Rapid chromatographic method to decipher distinct alterations in lipid classes in NAFLD/NASH.Fatty acids in non-alcoholic steatohepatitis: Focus on pentadecanoic acid.
P2860
Q30009096-82F0A550-80A1-4768-AF64-93013AD828F9Q31125724-3BA8DCCA-D87C-4051-BCFF-D3725CA84B36Q33594722-BD65111B-F29F-4960-B812-B1ADD1C93664Q33599367-1BB48626-680A-4E3C-9DBC-17C32CCE5268Q34217385-AB6085C0-E5CF-46DD-92ED-9C4895E8C8B9Q34252854-1FFFAB42-59B0-4926-A790-FB71CCF7E27FQ34309876-E70B4C56-F47E-4D8D-AB64-D528B99A0A51Q34750585-42FC62D2-4D4D-478F-A934-D5049CBD3714Q34992761-C09323D2-D180-4BDC-A40D-E843EAF56605Q35626025-F9AA14FA-43DE-4343-8559-A4D5E9FE69CEQ35705414-8BE1CB33-8A07-469A-AB0E-692847173414Q36015852-0EA51AFB-DFBF-4AD3-B8D3-3F2F8B5908D4Q36329899-A997F4FD-BD38-4AA3-93E4-F2C805360B81Q36360941-FA7E11ED-E428-44C2-BBDF-52DA6F0051CBQ36590606-A94350D7-439F-4BEF-A9AB-EB61A02592DFQ36609684-A2BF57D1-2805-42CE-A1EE-86278C939A58Q36673866-E067C1E5-6B8C-4FD3-A357-E10040335DC4Q36777552-7B330AD5-B919-4E96-B886-049FE1FF167BQ37002333-DB384092-C986-4673-99A0-317F27495E41Q37022229-A1AD9C85-2BC3-4692-9EDB-F157EB0AF3BFQ37054261-88E99826-B6CA-43F9-836E-03013A5A243CQ37166770-53B9D6A5-61C9-43B0-BE73-25FDAE1224E8Q38718555-00438F0F-82C5-4D9C-A85A-5B92DBC04BDDQ38723164-53896AF9-7739-4BE5-BEDD-55D66EB7AF35Q38726237-7C9FD39D-135D-47D0-8FE9-61BFA27ADCC7Q38726399-A45C563E-4BDA-4A1F-9EEE-6CEC1D5A35D0Q38827031-6C45CB7C-3C0A-46D2-AAFD-B60033D32832Q39047815-5B4C6267-25C9-4B40-A1C2-9EAEAB9127ACQ39134670-1F490B4F-E2B9-441C-A166-04B543D10E54Q39356501-F1F98B7F-48B6-43D6-9AC7-838503553472Q39639230-7F431170-AB58-4E66-A345-B4BB55518454Q39896001-BF42E51D-2092-47BA-942C-2D2E4960CC43Q40165759-04225CF7-F1C1-4F25-95DC-E9D4409DD9EEQ40202938-48C9B8BB-B535-453B-A741-60807DF90370Q41072298-1350A101-5640-442D-AADF-3EB652357868Q41557835-748A4F3A-74E0-4F1C-8470-7061E16FA9C2Q41924860-B6DA4B53-2324-4D4E-8F2C-31B560C58D17Q41926352-3E9CB8B7-BB40-4153-959C-E10D19A967F6Q42928898-98C1AACE-C28E-484E-B2A3-0FA8838FA0F9Q47150578-8A1E2A70-F3FA-4338-B4B1-BCCC8C297A0E
P2860
Proteomic and lipidomic signatures of lipid metabolism in NASH-associated hepatocellular carcinoma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 07 June 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Proteomic and lipidomic signat ...... ated hepatocellular carcinoma.
@en
Proteomic and lipidomic signat ...... ated hepatocellular carcinoma.
@nl
type
label
Proteomic and lipidomic signat ...... ated hepatocellular carcinoma.
@en
Proteomic and lipidomic signat ...... ated hepatocellular carcinoma.
@nl
prefLabel
Proteomic and lipidomic signat ...... ated hepatocellular carcinoma.
@en
Proteomic and lipidomic signat ...... ated hepatocellular carcinoma.
@nl
P2093
P2860
P1433
P1476
Proteomic and lipidomic signat ...... ated hepatocellular carcinoma.
@en
P2093
Antonious Hazim
Do-Young Kim
Laura Beretta
Marion Peyressatre
Xiaoling Song
P2860
P304
P356
10.1158/0008-5472.CAN-12-3797
P407
P577
2013-06-07T00:00:00Z